Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Related Reports
Market Research Reports provided by reports.innovaro.com
Aug 2008 - 120 pages - $1,040
Jan 2009 - $15,200
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Jan 2010 - $15,200
May 2011 - 43 pages - $500
Dec 2007 - 186 pages - $3,140
Nov 2010 - 40 pages - $500
Aug 2008 - 352 pages - $2,615
May 2011 - 15 pages - $250
Your selection
Browse By
- Industry sector
- Advertising
- Business services
- Clinical research
- Communications
- Consultancy
- Distribution
- Event management
- Finance
- Information technology
- Laboratory equipment
- Legal
- Manufacturing
- Market research
- Marketing
- Materials
- Medical education
- Packaging
- Patents
- Pharmacovigilance
- Product development
- Public relations
- Publishers
- Recruitment
- Regulatory affairs
- Research
- Training
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us